In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz

被引：0
|
作者：
Kollmann, C
Tremblay, C
Giguel, F
Chou, TC
Hirsch, MS [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Program Virol, Boston, MA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
ANTIVIRAL THERAPY | 2001年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [1] HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors
    Wainberg, MA
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 : S2 - S7
  • [2] Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models
    Mastan, S. K.
    Kumar, K. Eswar
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2009, 1
  • [3] Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models
    SK Mastan
    K Eswar Kumar
    [J]. Diabetology & Metabolic Syndrome, 1
  • [4] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [5] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [6] Convenient route to efavirenz analogues as potential non-nucleoside HIV-1 reverse transcriptase inhibitors
    Hamed, AA
    [J]. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES, 2004, 59 (05): : 589 - 596
  • [7] Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents
    Famiglini, Valeria
    La Regina, Giuseppe
    Coluccia, Antonio
    Masci, Domiziana
    Brancale, Andrea
    Badia, Roger
    Riveira-Munoz, Eva
    Este, Jose A.
    Crespan, Emmanuele
    Brambilla, Alessandro
    Maga, Giovanni
    Catalano, Myriam
    Limatola, Cristina
    Formica, Francesca Romana
    Cirilli, Roberto
    Novellino, Ettore
    Silvestri, Romano
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (15) : 6528 - 6547
  • [8] Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy
    Zeng, Zhao-Sen
    He, Qiu-Qin
    Liang, Yong-Hong
    Feng, Xiao-Qing
    Chen, Fen-Er
    De Clercq, Erik
    Balzarini, Jan
    Pannecouque, Christophe
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 5039 - 5047
  • [9] Non-Nucleoside Reverse Transcriptase Inhibitors Efavirenz and Nevirapine Inhibit Cytochrome C Oxidase in Mouse Brain Regions
    Streck, Emilio L.
    Ferreira, Gabriela K.
    Scaini, Giselli
    Rezin, Gislaine T.
    Goncalves, Cinara L.
    Jeremias, Isabela C.
    Zugno, Alexandra I.
    Ferreira, Gustavo C.
    Moreira, Jeverson
    Fochesato, Celine M.
    Romao, Pedro R. T.
    [J]. NEUROCHEMICAL RESEARCH, 2011, 36 (06) : 962 - 966
  • [10] Non-Nucleoside Reverse Transcriptase Inhibitors Efavirenz and Nevirapine Inhibit Cytochrome C Oxidase in Mouse Brain Regions
    Emilio L. Streck
    Gabriela K. Ferreira
    Giselli Scaini
    Gislaine T. Rezin
    Cinara L. Gonçalves
    Isabela C. Jeremias
    Alexandra I. Zugno
    Gustavo C. Ferreira
    Jeverson Moreira
    Celine M. Fochesato
    Pedro R. T. Romão
    [J]. Neurochemical Research, 2011, 36 : 962 - 966
12345